Akboga, M. Et Al. 2015. Increased serum YKL-40 is a novel marker of metabolic syndrome in adult patients. Congress of the European-Society-of-Cardiology (ESC) , (London, Canada), 780.

Akboga, M., Yalcin, R., Sahinarslan, A., Demirtas, C., CANPOLAT, U., Pasaoglu, H., ... Aras, D.(2015). Increased serum YKL-40 is a novel marker of metabolic syndrome in adult patients . Congress of the European-Society-of-Cardiology (ESC) (pp.780). London, Canada

Akboga, M. Et Al. "Increased serum YKL-40 is a novel marker of metabolic syndrome in adult patients," Congress of the European-Society-of-Cardiology (ESC), London, Canada, 2015

Akboga, M. Et Al. "Increased serum YKL-40 is a novel marker of metabolic syndrome in adult patients." Congress of the European-Society-of-Cardiology (ESC) , London, Canada, pp.780, 2015

Akboga, M. Et Al. (2015) . "Increased serum YKL-40 is a novel marker of metabolic syndrome in adult patients." Congress of the European-Society-of-Cardiology (ESC) , London, Canada, p.780.

@conferencepaper{conferencepaper, author={M. Akboga Et Al. }, title={Increased serum YKL-40 is a novel marker of metabolic syndrome in adult patients}, congress name={Congress of the European-Society-of-Cardiology (ESC)}, city={London}, country={Canada}, year={2015}, pages={780} }